ArticleClinical case reports2021
Post-COVID-19 co-morbidity of emerged
Article in Clinical case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Development and Validation of In-House Conventional and Multiplex PCR Methods for the Detection and Identification of Lophomonas spp.: An Innovative Approach.Journal of clinical laboratory analysis · 2025Article
- Ruptured pulmonary hydatid cyst and lophomoniasis comorbidity in a young man: a rare case.Oxford medical case reports · 2023Article
- Article
- Post-COVID-19 maxillary osteonecrosis and floating maxillary teeth due to mucormycosis in two uncontrolled diabetic patients.Clinical case reports · 2022Article
- First report of emerged pulmonary lophomoniasis in two Afghanian medical tourists.Clinical case reports · 2022Article
- First report ofRespirology case reports · 2022Article
- Molecular evidence of upper and lower respiratory infection due toClinical case reports · 2022Article
- Fungal, parasitological, and bacterial coinfection in a severely ill COVID-19 patient in Peru.Clinical case reports · 2022Article
- Global Status of EmergingInterdisciplinary perspectives on infectious diseases · 2022Review
- Detection ofSAGE open medical case reports · 2022Article
- Post-COVID-19 co-morbidity of emergedClinical case reports · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Due to long corticosteroid therapy in patients with COVID-19, in case of cough, dyspnea, and weight loss, emerging pulmonary aspergillosis and lophomoniasis should be ruled out.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.